[1]
2026. Design Strategy and In-Silico Investigation of Indole-Functionalized Isoxazoles as Potential Antiparkinsonism Activity. International Journal of Research in Pharmaceutical Sciences and Technology. 9, 3 (Aug. 2026). DOI:https://doi.org/10.33974/r8r8je74.